期刊文献+

沉默Dyrk1B基因对宫颈癌细胞生物学功能的影响 被引量:1

Effect of silencing Dyrk1B on biological function of cervical cancer cells
原文传递
导出
摘要 目的通过沉默在宫颈癌C4-1和Hela细胞Dyrk1B基因,观察Dyrk1B基因对宫颈癌细胞生物学功能的影响。方法应用慢病毒转染宫颈癌C4-1和Hela细胞沉默Dyrk1B基因作为沉默组,同时以空载病毒转染组为对照组。通过荧光显微镜观察2组转染效率,采用RT-PCR法检测Dyrk1B mRNA表达水平,采用流式细胞仪检测细胞凋亡率,四甲基偶氮唑蓝(MTT)比色法检测细胞增殖能力以及对DDP的敏感性。结果慢病毒转染宫颈癌C4-1和Hela细胞转染效率无差异,沉默组Dyrk1B mRNA表达均低于空载对照组,宫颈癌C4-1和Hela细胞沉默组细胞的凋亡率较空载对照组增加,而宫颈癌C4-1细胞沉默组增殖较空载对照组降低,宫颈癌C4-1和Hela细胞沉默组较空载对照组比较IC50值均降低。结论慢病毒转染宫颈癌C4-1和Hela细胞沉默Dyrk1B基因表达可增加凋亡率,而细胞增殖能力下降,并且提高宫颈癌C4-1和Hela细胞对顺铂的敏感性。 Objective To observe the effect of silencing Dyrk1B gene on the biological function of cervical cancer C4-1 and Hela cells. Methods Dyrk1B gene of human cervical cancer C4-1 and Hela cells silenced by Lentivirus carriing were enrolled into the silence group. The control group was transfected with an empty lentivirus. The transfection efficiency of two groups was observed by fluorescence microscopy. Real Time fluorescent quantitative PCR(qPCR) was used to detect mRNA expression of Dyrk1B gene, and flow cytometry was used to detect cell apoptosis rate, while methyl thiazolyl tetrazolium(MTT) colorimetry was used to detect their sensitivity to DDP. Results There was no difference in the transfection efficiency of C4-1 and Hela cells transfected by lentiviral. The expression of Dyrk1B mRNA in the silence group was lower than that in the control group. The apoptosis rate of C4-1 and Hela cells in silence group was higher than that in the control group, but the proliferation of the C4-1 cell in silence group was lower than that of the control group. The IC50 values of the C4-1 and Hela cells in the silence group were lower than those in the control group. Conclusion The silencing of Dyrk1B gene by lentiviral transfection increases the apoptosis rate and decreases the cell proliferation ability of cervical cancer C4-1 and Hela cells. And silenceing Dyrk1B gene can increase the sensitivity of C4-1 and Hela cells to cisplatin.
作者 方来福 刘敏杰 解友邦 丛玲华 任莹 钟国平 FANG Lai-fu;LIU Min-jie;XIE You-bang;CONG Ling-hua;REN Ying;ZHONG Guo-ping(Department of Obstetrics and Gynecology, Yinzhou People's Hospital, Ningbo, Zhejiang 315040, China)
出处 《中国卫生检验杂志》 CAS 2019年第11期1292-1294,1302,共4页 Chinese Journal of Health Laboratory Technology
基金 宁波市科技局科技惠民计划项目(2015C50015) 宁波市科技局自然科学基金(2013A610229)
关键词 宫颈癌细胞 Dyrk1B 细胞增殖和凋亡 化疗敏感性 Cervical cancer cells Dyrk 1 B Proliferation and apoptosis Chemotherapy sensitivity
  • 相关文献

参考文献1

二级参考文献12

  • 1Mercer SE,Ewton DZ,Shah S,et al.Mirk/Dyrklb mediates cell survival in rhabdomyosarcomas[J].Cancer Res,2006,66(10):5143-5150.
  • 2Deng X,Ewton DZ,Li S,et al.The kinase Mirk/DyrklB mediates cell survival in pancreatic ductal adenocarcinoma[J].Cancer Res,2006,66(8):4149-4158.
  • 3Gao J,Zheng Z,Rawal B,et al.Mirk/DyrklB,a novel therapeutic target,mediates cell survival in non-small cell lung cancer cells[J].Cancer Biol Ther,2009,8(17):1671-1679.
  • 4Lee K,Deng X,Friedman E.Mirk protein kinase is a mitogen-activated protein kinase substrate that mediates survival of colon cancer cells[J].Cancer Res,2000,60(13):3631-3637.
  • 5Hu J,Friedman E.Depleting Mirk kinase increases cisplatin toxicity in ovarian cancer cells[J].Genes Cancer,2010,1(8):803-811.
  • 6Zhou N,Yuan S,Wang R,et al.Role of dual specificity tyrosine-phosphorylation-regulated kinase IB (DyrklB) in S-phase entry of HPV E7 expressing cells from quiescence[J].Oncotarget,2015,6(31):30745-30761.DOI:10.18632/ oncotarget.5222.
  • 7Becker W,Weber Y,Wetzel K,et al.Sequence characteristics,subcellular localization,and substrate specificity of DYRK-related kinases,a novel family of dual specificity protein kinases[J].J Biol Chem,1998,273(40):25893-25902.
  • 8Leder S,Weber Y,Altafaj X,et al.Cloning and characterization of DYRK1B,a novel member of the DYRK family of protein kinases[J].Biochem Biophys Res Commun,1999,254(2):474-479.
  • 9Hu J,Deng H,Friedman EA.Ovarian cancer cells,not normal cells,are damage d by Mirk/DyrklB kinase inhibition[J].Int J Cancer,2013,132(10):2258-2269.DOI:10.1002/ijc.27917.
  • 10Yang C,Ji D,Weinstein EJ,et al-The kinase Mirk is a potential therapeutic target in osteosarcoma[J].Carcinogenesis,2010,31(4):552-558.DOI:10.1093/carcin/bgp330.

共引文献8

同被引文献6

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部